Functional consequences of the SHP-1 defect in motheaten viable mice: role of NF-kappa B

Cellular Immunology
A R KhaledJ Schiffenbauer

Abstract

To define the functional consequences of the src-homology domain-1 protein (SHP-1) defect, we examined cytokine production and NF-kappa B activity in motheaten viable (Mev) mice. We found elevated levels of interleukin-6 (IL-6), interleukin-10 (IL-10), tumor necrosis factor (TNF), and interferon-gamma (IFN-gamma) in Mev mice sera and cultured B and T cells compared to littermate control adult mice. The levels of interleukin-2 (IL-2) detected in Mev sera and activated Mev T cells were decreased, but IL-2 receptor expression was increased. We then evaluated the activity of NF-kappa B and found that this protein is highly expressed in Mev B and T cells. To determine if NF-kappa B had a role in causing the elevated levels of cytokines in Mev mice, we treated activated Mev T cells with an NF-kappa B decoy and found that cell culture treatment with the decoy resulted in significant reduction of the secretion of IL-6, GM-CSF, and TNF, but not IFN-gamma. Therefore, our data show that Mev mice secrete elevated levels of inflammatory cytokines, which can be mediators in the development of the Mev clinical disorder, and that NF-kappa B has an important role in this process, impacting upon the regulation of the immune response.

References

Mar 1, 1981·Immunogenetics·E A ClarkS B Pollack
Jan 1, 1993·Journal of Clinical Immunology·M al-JanadiS Raziuddin

❮ Previous
Next ❯

Citations

Sep 23, 2008·Proceedings of the National Academy of Sciences of the United States of America·Ben A CrokerBruce Alan Beutler
Apr 16, 2005·Clinical Microbiology Reviews·Martin OlivierGeneviève Forget
Oct 2, 2008·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Satoshi Ichikawa
Dec 24, 2011·Cancer Immunology, Immunotherapy : CII·Jurjen TelI Jolanda M de Vries
Apr 17, 2010·Journal of Biomedicine & Biotechnology·Suvercha BhardwajBhaskar Saha
Feb 21, 2006·Biochemical and Biophysical Research Communications·Amy O HardinB Keith English
Apr 29, 2009·Laboratory Investigation; a Journal of Technical Methods and Pathology·George P ChristophiPaul T Massa
Jan 23, 2008·Laboratory Investigation; a Journal of Technical Methods and Pathology·George P ChristophiPaul T Massa
Aug 21, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·F LopezC Susini
Mar 1, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ying WangMonica Kraft
May 20, 2005·European Journal of Immunology·Geneviève ForgetMartin Olivier
May 28, 2019·Emerging Microbes & Infections·Ruixue ZhouDapeng Yan
Aug 2, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Chinonso OkenwaMaya Kozlowski
Feb 23, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Zia U A MollahRanjeny Thomas
Feb 12, 2021·The Journal of Immunology : Official Journal of the American Association of Immunologists·Huan HeDapeng Yan
Feb 2, 2008·The Journal of Organic Chemistry·Masanori NakaneAkira Matsuda

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.